Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”

Abstract EN

The article titled “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors” [1] was found to contain material in Sections 1, 2, and 3 from published work and to have missing attributions and errors in citations.

The articles are as follows:(i)M.

T.

Heneka and G.

E.

Landreth, “PPARs in the brain,” Biochimica et Biophysica Acta, vol.

1771, no.

8, pp.

1031–1045, 2007.

https://doi.org/10.1016%2fj.bbalip.2007.04.016.

[2] (Cited as reference [36]).(ii)Lars Tatenhorst, Eric Hahnen, and Michael T.

Heneka, “Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors,” PPAR Research, vol.

2008, Article ID 204514, 9 pages, 2008.

https://doi.org/10.1155/2008/204514.

[3] (not cited).(iii)Markus P.

Kummer and Michael T.

Heneka, “PPARs in Alzheimer’s Disease,” PPAR Research, vol.

2008, Article ID 403896, 8 pages, 2008.

https://doi.org/10.1155/2008/403896.

[4] (not cited).(iv)J.

N.

Feige, L.

Gelman, L.

Michalik, B.

Desvergne, and W.

Wahli, “From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions,” Progress in Lipid Research, vol.

45, no.

2, pp.

120–159, 2006.

https://doi.org/10.1016%2fj.plipres.2005.12.002.

[5] (cited as reference [30]).(v)A.

Cimini, E.

Benedetti, L.

Cristiano et al., “Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons,” Neuroscience, vol.

130, no.

2, pp.

325–337, 2005.

https://doi.org/10.1016%2fj.neuroscience.2004.09.043.

[6] (cited as reference [81]).